• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.49% Nasdaq Up0.69%

    Infinity Pharmaceuticals, Inc. (INFI)

    -NasdaqGS
    17.50 Up 0.31(1.82%) 3:39PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 160,639   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit 160,639   -   -   -  
    Operating Expenses
    Research Development44,895  28,165  34,491  26,592  
    Selling General and Administrative8,042  7,057  6,804  6,492  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 107,702   (35,222) (41,295) (33,084)
    Income from Continuing Operations
    Total Other Income/Expenses Net52  136  168  159  
    Earnings Before Interest And Taxes107,754  (35,086)(41,127)(32,925)
    Interest Expense4,538  2,938  1,139   -  
    Income Before Tax103,216  (38,024)(42,266)(32,925)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops103,216  (38,024)(42,266)(32,925)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 103,216   (38,024) (42,266) (32,925)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 103,216   (38,024) (42,266) (32,925)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.